Skip to main content

Mutations accumulate in both normal and diseased tissues with age and are thought to drive increasing risk of cancer. Kow Essuman is interested in better understanding how mutations accumulate in the human brain, and how mutations drive brain tumor growth. Using single cell sequencing technologies on brain tissues from normal individuals and from individuals with the brain tumor predisposition syndrome NF1, Essuman hopes to uncover genetic drivers and therapeutic targets for brain cancer.